"Since 1978, Indiana Heart Physicians in Indianapolis has proudly served patients in Indiana with the highest quality cardiovascular care. Saturday and evening appointments are available."

During the past decade, Franciscan Physician Network - Indiana Heart Physicians conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Franciscan Physician Network - Indiana Heart Physicians" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Akebia Therapeutics" with 1 trials sponsored, "American Regent, Inc." with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Franciscan Physician Network - Indiana Heart Physicians" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Franciscan Physician Network - Indiana Heart Physicians" are "Heart Failure" (5 trials), "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Angina Pectoris" (1 trials). Many other conditions were trialed in "Franciscan Physician Network - Indiana Heart Physicians" in a lesser frequency.

Most popular intervention types in "Franciscan Physician Network - Indiana Heart Physicians" are "Drug" (12 trials), "Device" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apixaban" (2 trials), "Empagliflozin" (2 trials), "AMPLATZER PFO Occluder" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Franciscan Physician Network - Indiana Heart Physicians" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Franciscan Physician Network - Indiana Heart Physicians". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Franciscan Physician Network - Indiana Heart Physicians, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Franciscan Physician Network - Indiana Heart Physicians, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".